AnalystsZegbeh Jallah
Zegbeh Jallah's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 6%
#260 out of 4873 analysts
Average Return
+74.4%
Win Rate
26%6 out of 23
Risk vs Reward
Poor
Good

Zegbeh Jallah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+2,086.21%$0.29$6.34
2020-11-16 -
2021-06-11
Strong Buy
Ideaya Biosciences IncIDYA
+469.48%$4.03$22.95
2020-03-12 -
2021-03-12
Strong Buy
Ideaya Biosciences IncIDYA
+102.29%$17.47$35.34
2022-12-27 -
2023-12-27
Buy
Rapt Therapeutics IncRAPT
+13.94%$16.93$19.29
2020-04-12 -
2021-04-13
Strong Buy
Clearside Biomedical IncCLSD
+12.08%$2.07$2.32
2020-05-12 -
2021-05-13
Strong Buy

Zegbeh Jallah Analyst Color

Get additional color on Zegbeh Jallah's coverage of popular stocks

Zegbeh Jallah's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Outlook Therapeutics IncOTLK
2Buy$100.00N/AUpgrades
a year ago
Glycomimetics IncGLYC
1Buy$12.00N/AInitiates Coverage On
a year ago
Eyepoint Pharmaceuticals IncEYPT
1Buy$44.00N/AInitiates Coverage On
a year ago
Kodiak Sciences IncKOD
3Hold$7.00N/ADowngrades
2 years ago
Ideaya Biosciences IncIDYA
2Buy$29.00N/AInitiates Coverage On
2 years ago
Rapt Therapeutics IncRAPT
2Buy$48.00N/AInitiates Coverage On
3 years ago
Enanta Pharmaceuticals IncENTA
2Strong Buy$70.00N/AMaintains
3 years ago
Syros Pharmaceuticals IncSYRS
1Strong Buy$230.00N/AMaintains
4 years ago
Atyr Pharma IncATYR
2Strong Buy$21.00N/AMaintains
4 years ago
Rezolute IncRZLT
1Strong Buy$21.00N/AInitiates Coverage On
4 years ago
Arvinas IncARVN
1Strong Buy$135.00N/AMaintains
4 years ago
Dare Bioscience IncDARE
1Strong Buy$132.00N/AMaintains
4 years ago
Ocugen IncOCGN
2Hold$6.00N/ADowngrades
4 years ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$55.00N/AMaintains
4 years ago
Applied Genetic Technologies CorpAGTC
2Strong Buy$35.00N/AMaintains
4 years ago
Clearside Biomedical IncCLSD
1Strong Buy$8.00N/AInitiates Coverage On
5 years ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$600.00N/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.